Correction: Effect of alirocumab on cataracts in patients with acute coronary syndromes

• Gaspard Suc,
• Gregory G. Schwartz,
• Shaun G. Goodman,
• J. Wouter Jukema,
• Garen Manvelian,
• Yann Poulouin,
• Robert Pordy,
• Michel Scemama,
• Michael Szarek,
• Ph.Gabriel Steg,
• ODYSSEY OUTCOMES Investigators

Affiliations

Gaspard Suc

Université Paris-Cité, INSERM_U1148/LVTS

Gregory G. Schwartz

Division of Cardiology, University of Colorado School of Medicine

Shaun G. Goodman

Canadian VIGOUR Centre, University of Alberta

J. Wouter Jukema

Department of Cardiology, Leiden University Medical Center

Garen Manvelian

Regeneron Pharmaceuticals

Yann Poulouin

IT&M Stats

Robert Pordy

Regeneron Pharmaceuticals

Michel Scemama

Sanofi

Michael Szarek

Downstate School of Public Health, State University of New York

Ph.Gabriel Steg

Université Paris-Cité, INSERM_U1148/LVTS

ODYSSEY OUTCOMES Investigators

Université Paris-Cité, INSERM_U1148/LVTS